Evidence map›Paper›PMID 26416268›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

A Gene Expression Signature That Correlates with CD8+ T Cell Expansion in Acute EBV Infection.

Thomas C Greenough, Juerg R Straubhaar, Larisa Kamga, Eric R Weiss, Robin M Brody, Margaret M McManus, Linda K Lambrecht, Mohan Somasundaran, Katherine F Luzuriaga

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. CD8Theranostics · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. CD8Multiple sclerosis journal - experimental, translational and clinical
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Thomas C GreenoughDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA 01605; and.
Juerg R StraubhaarProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605.
Larisa KamgaProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605.
Eric R WeissProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605.
Robin M BrodyProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605.
Margaret M McManusProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605.
Linda K LambrechtProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605.
Mohan SomasundaranProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605.
Katherine F LuzuriagaProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605 Katherine.luzuriaga@umassmed.edu.
University of Massachusetts Chan Medical School · US

Funding

Tetramer CoreP01AI049320 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KONZ, RICHARD FREDERICK · 2001 to 2016
$22.3M
UMASS MEDICAL CENTER FOR AIDS RESEARCHP30AI042845 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SCHIFFER, CELIA A. · 1998 to 2012
$13.0M
University of Massachusetts Center for Clinical and Translational ScienceUL1TR000161 · NCATS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LUZURIAGA, KATHERINE F · 2012 to 2015
$11.0M
NCATS NIH HHS UL1 TR000161NCATS NIH HHS UL1TR000161NIAID NIH HHS P01 AI049320NIAID NIH HHS P30 AI042845NIAID NIH HHS P30AI042845
6 · The paper itself

Abstract

Virus-specific CD8(+) T cells expand dramatically during acute EBV infection, and their persistence is important for lifelong control of EBV-related disease. To better define the generation and maintenance of these effective CD8(+) T cell responses, we used microarrays to characterize gene expression in total and EBV-specific CD8(+) T cells isolated from the peripheral blood of 10 individuals followed from acute infectious mononucleosis (AIM) into convalescence (CONV). In total CD8(+) T cells, differential expression of genes in AIM and CONV was most pronounced among those encoding proteins important in T cell activation/differentiation, cell division/metabolism, chemokines/cytokines and receptors, signaling and transcription factors (TF), immune effector functions, and negative regulators. Within these categories, we identified 28 genes that correlated with CD8(+) T cell expansion in response to an acute EBV infection. In EBV-specific CD8(+) T cells, we identified 33 genes that were differentially expressed in AIM and CONV. Two important TF, T-bet and eomesodermin, were upregulated and maintained at similar levels in both AIM and CONV; in contrast, protein expression declined from AIM to CONV. Expression of these TF varied among cells with different epitope specificities. Collectively, gene and protein expression patterns suggest that a large proportion, if not a majority of CD8(+) T cells in AIM are virus specific, activated, dividing, and primed to exert effector activities. High expression of T-bet and eomesodermin may help to maintain effector mechanisms in activated cells and to enable proliferation and transition to earlier differentiation states in CONV.

Indexed as

TranscriptomeAcute DiseaseAdolescentADP-ribosyl Cyclase 1AdultCD8-Positive T-LymphocytesFemaleHerpesvirus 4, HumanHumansInfectious MononucleosisMaleReceptors, Interleukin-7Transcription FactorsADP-ribosyl Cyclase 1Receptors, Interleukin-7Transcription Factors

Identifiers

PMID26416268
PMCPMC4610856
OpenAlexW2221519658

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.